Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis
暂无分享,去创建一个
D. Gu | Jie Tian | N. Hong | Jingwei Wei | W. Sheng | T. Tong | Yuqi Han | Y. Ye | Jin Cheng | Yi Wang | Yali Yue | Yinli Zhang | Fan Chai
[1] D. Gu,et al. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method , 2019, Annals of Surgical Oncology.
[2] D. Dong,et al. Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study , 2019, Clinical and translational gastroenterology.
[3] Yanhui Ding,et al. Stability of MRI Radiomics Features of Hippocampus: An Integrated Analysis of Test-Retest and Inter-Observer Variability , 2019, IEEE Access.
[4] Antoine Vacavant,et al. Automatic segmentation methods for liver and hepatic vessels from CT and MRI volumes, applied to the Couinaud scheme , 2019, Comput. Biol. Medicine.
[5] M. Ravanelli,et al. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy , 2019, La radiologia medica.
[6] H. Ulmer,et al. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score , 2019, PloS one.
[7] Luc Y Dirix,et al. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases , 2019, Angiogenesis.
[8] R. Labianca,et al. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group. , 2018, European journal of cancer.
[9] B. Bozóky,et al. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review , 2018, BMJ open gastroenterology.
[10] Hyunjin Park,et al. Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer , 2018, Clinical Cancer Research.
[11] P. Vermeulen,et al. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti‐angiogenic therapies , 2018, The journal of pathology. Clinical research.
[12] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[13] Lawrence H. Schwartz,et al. Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab , 2017, Neuro-oncology.
[14] Yves Sucaet,et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis , 2017, British Journal of Cancer.
[15] Sohil H. Patel,et al. T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project , 2017, Clinical Cancer Research.
[16] John Quackenbush,et al. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.
[17] N. Paragios,et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] E. Wallen,et al. Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study , 2017, Scientific Reports.
[19] M. Cheetham,et al. The multimorbidity interaction severity index (MISI) , 2017, Medicine.
[20] G. G. Van den Eynden,et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases , 2016, Nature Medicine.
[21] M. Götz,et al. Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response , 2016, Clinical Cancer Research.
[22] Yanqi Huang,et al. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. , 2016, Radiology.
[23] P. Soler-Palacín,et al. Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients , 2016, Medicine.
[24] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[25] A. Shinagare,et al. Update on the role of imaging in management of metastatic colorectal cancer. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.
[26] P. Lambin,et al. Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability , 2013, Acta oncologica.
[27] G. Jayson,et al. Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors? , 2012, Clinical Cancer Research.
[28] I. Christensen,et al. Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases , 2012, Journal of oncology.
[29] G. G. Van den Eynden,et al. The histological growth pattern of colorectal cancer liver metastases has prognostic value , 2012, Clinical & Experimental Metastasis.
[30] A. Jackson,et al. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.
[31] Brandon Whitcher,et al. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 , 2011, British Journal of Cancer.
[32] Feiping Nie,et al. Efficient and Robust Feature Selection via Joint ℓ2, 1-Norms Minimization , 2010, NIPS.
[33] E. van Marck,et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia , 2001, The Journal of pathology.
[34] K. Hatakeyama,et al. Computed tomographic features of colorectal carcinoma liver metastases predict posthepatectomy patient survival , 2001, Diseases of the colon and rectum.
[35] R. Semelka,et al. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. , 2000, Radiology.